Answers are grounded in this paper and cite their sources.
This analysis examines legal challenges in stem cell therapy in China, suggesting improvements for compliance and development.
Currently, due to their powerful multidirectional differentiation potential and self-renewal capability, stem cells have demonstrated unprecedented therapeutic potential and application prospects in the medical field, sparking a global wave of stem cell technology research, development, and industrialization. This paper will systematically analyze the current status of legal regulation and problems exposed in practice within China's stem cell therapy field. It will draw on foreign legal systems and advanced experiences and, ultimately, propose specific suggestions for improving China's legal regulation of stem cell therapy, thereby fostering its healthy and orderly development within a legal and compliant framework.
No takes yet. Share an insight, caveat, or question.
Xinyue et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: